Skip to content

An observational study to evaluate driving competence in Huntington's disease

An observational study to evaluate driving competence in Huntington's disease - Evaluating driving competence in HD (Drive-HD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43584
Enrollment
90
Registered
2016-02-24
Start date
2016-06-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Huntington's disease movement disorder

Interventions

None listed

Sponsors

Centre for Human Drug Research
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All eligible subjects must meet the following inclusion criteria: - be at least 18 years of age; - possess a valid Dutch driver's licence; - driven at least 300 km in the 12 months prior to study entry, to ensure regular driving activity.;Additional inclusion criteria HD manifest subjects - confirmed CAG expansion of *36 in the HTT gene; - UHDRS TMS >5.;Additional inclusion criteria for HD premanifest gene carriers - confirmed CAG expansion of *36 in the HTT gene; - UHDRS TMS *5, and no diagnosis in any other HD related domain (i.e. cognition or psychiatric).;Additional inclusion criteria for control subjects - Gene negative for HD or no family history of HD, preferably spouses or relatives of HD subjects.

Exclusion criteria

Exclusion criteria: All eligible subjects must meet none of the following exclusion criteria: - Major comorbidities that are unrelated to HD (i.e. isolated psychiatric disorder, other neurological disorder, paralysis, ophthalmic disorder); - Drug use (i.e. not medication) in the past 3 till 4 weeks prior to the visit day; - Alcohol abuse (i.e. 3 or more glasses per day); - Participation in intervention/clinical trials; - Any other condition that in the opinion of the investigator warrants exclusion of the study.

Design outcomes

Primary

MeasureTime frame
Primary end-points: - difference between the groups in number of errors on the outcome variables of the driving simulator. - difference between the groups in scores on the neuropsychological and motor assessments. Outcome measures: Driving simulator - Standard Deviation of Lateral Position (SDLP) - Mean, maximum and standard deviation of vehicle speed - Velocity, acceleration, position on the road, right of way, distance to preceding car, time to collision Neuropsychological and behavioural assessments - SDMT: total number of correct responses in 90 seconds - Stroop: total number of correct responses per trial - TMT: completion time in seconds for each trial - SART: the total number of errors - Adaptive tracking task: average performance (%) - PBA-s: total score per domain defined as severity multiplied by frequency Motor assessments - UHDRS TMS: total motor score (range 0-124) - UHDRS TFC: total functional score (range 0-13) - Finger tapping: mean tapping rate and standard deviation - Saccadic eye movements: saccadic reaction time (seconds), saccadic peak velocity (degrees/second), saccadic inaccuracy (%) - Smooth pursuit eye movements: percentage of time the eyes are in smooth pursuit of the target (%) - Body sway: antero-posterior sway (mm) Questionnaires and evaluation - FrsBe: overall total score and total score per subscale - HADS-SIS: total scores per domain - Evaluation: grade given by patient and companion

Secondary

MeasureTime frame
Secondary end-points: - a correlation between behavioural changes, as measured using the PBA-s, and driving capacities. - difference between a patient*s self-appraisal about their driving skills, a companion's appraisal, and the performance on the simulator and neuropsychological assessments.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)